BCI是一种双特异性磷酸酶(DUSP)的变构抑制剂,(E)-BCI 特异性抑制 DUSP6 和 DUSP1,细胞中的 EC50 分别为 13.3 μM 和 8.0 μM,但不抑制 DUSP5。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | BCI is a DUSP6 inhibitor. BCI has anti-inflammatory activity and reduces the production of reactive oxygen species (ROS). BCI can be used in inflammatory disease studies[1][2].At a concentration of 100 ng/mL for 24 h, BCI down-regulated DUSP6 expression in RAW264.7 macrophages. At a concentration of 1 nM for 24 h, BCI inhibited the expression of IL-1β and IL-6 in lipid LPS-activated macrophages. At a concentration of 4 nM for 24 h, BCI reduced ROS production and activated the Nrf2 pathway in LPS-activated macrophages[2]. |
| Concentration | Treated Time | Description | References | |
| STS26T MPNST cells | 2-4 μM | 72 h | Evaluate the effect of BCI on MPNST cell growth, results showed cells were less sensitive to BCI | Clin Cancer Res. 2019 Jul 1;25(13):4117-4127. |
| iHSC-1λ Schwann cells | 2-4 μM | 72 h | Evaluate the effect of BCI on Schwann cell growth, results showed cells were less sensitive to BCI | Clin Cancer Res. 2019 Jul 1;25(13):4117-4127. |
| S462.TY MPNST cells | 2-4 μM | 72 h | Evaluate the effect of BCI on MPNST cell growth, results showed BCI significantly inhibited cell growth | Clin Cancer Res. 2019 Jul 1;25(13):4117-4127. |
| ST8814 MPNST cells | 2-4 μM | 72 h | Evaluate the effect of BCI on MPNST cell growth, results showed BCI significantly inhibited cell growth | Clin Cancer Res. 2019 Jul 1;25(13):4117-4127. |
| HeLa cells | 10 μM | 15 min | BCI treatment restored p-ERK levels in Dusp6-Myc transfected cells, indicating that BCI directly inhibited Dusp6-Myc function | Nat Chem Biol. 2009 Sep;5(9):680-7. |
| Mouse bone marrow-derived macrophages (BMMs) | 1 μM | 6 days | To investigate the effect of (E/Z)-BCI on osteoclast differentiation, results showed that (E/Z)-BCI significantly accelerated osteoclastogenesis. | Cell Death Dis. 2021 Sep 2;12(9):825. |
| BaF3 cells | 400 nM | 1 week | To evaluate the effect of BCI on CSF3R mutant-induced CFU formation, results showed that BCI alone or in combination with ruxolitinib significantly suppressed CSF3R mutant-induced CFU formation. | Blood Adv. 2024 Jun 11;8(11):2765-2776. |
| SH-SY5Y neuroblastoma cells | 5 μM | 24 h | BCI enhances P2X7 receptor expression | Front Cell Dev Biol. 2022 Dec 15;10:1049566. |
| N2a neuroblastoma cells | 5 μM | 24 h | BCI enhances P2X7 receptor expression | Front Cell Dev Biol. 2022 Dec 15;10:1049566. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Jak2V617F-induced MPN model | Oral | 100 mg/kg | Daily, for 40 weeks | Evaluate the selective eradication effect of BCI on Jak2V617F clones | Leukemia. 2023 Aug;37(8):1686-1697. |
| Zebrafish | Ventricular resection model | Intraperitoneal injection | 10 µM | Once daily until hearts were collected | BCI promotes heart regeneration by inhibiting Dusp6 | Cell Res. 2014 Sep;24(9):1091-107 |
| Nude mice | S462.TY cell line xenograft model | Intraperitoneal injection | 10 mg/kg | Once daily, 5x/wk for 27 days | Evaluate the effect of BCI on MPNST xenograft model, results showed no significant difference in tumor volume but tumor tissue exhibited necrosis | Clin Cancer Res. 2019 Jul 1;25(13):4117-4127. |
| Zebrafish | Transgenic zebrafish embryos | Immersion | 5 μM | From the 1000-cell stage | BCI treatment enhanced FGF signaling, leading to increased transcription of several FGF target genes | Nat Chem Biol. 2009 Sep;5(9):680-7. |
| C57BL/6J mice | Ovariectomy-induced osteoporosis model | Intraperitoneal injection | 30 mg/kg | Twice a week for 6 weeks | To investigate the effect of (E/Z)-BCI on osteoporosis in vivo, results showed that (E/Z)-BCI significantly accelerated the bone loss process. | Cell Death Dis. 2021 Sep 2;12(9):825. |
| NSG mice | Orthotopic model of prostate cancer | Intraperitoneal injection | 10 mg/kg | Five consecutive days per week, until experimental endpoint | BCI inhibits DUSP6 activity and prevents tumor formation induced by FBXO31 knockout | Cell Rep. 2021 Oct 19;37(3):109870 |
| Mice | Conventionally-raised wild-type mice and Dusp6-deficient mice | Intraperitoneal injection | 5 μg/g | Once a day during CR period | Investigate the role of DUSP6 inhibitor BCI in maintaining cold-adapted microbiota and promoting white adipose tissue browning after cold exposure | NPJ Biofilms Microbiomes. 2024 Mar 13;10(1):22 |
| Mice | CSF3R-induced leukemia model | Intraperitoneal injection | 10 mg/kg | Twice daily for 8 weeks | To evaluate the therapeutic effect of BCI alone or in combination with trametinib on CSF3R-induced leukemia, results showed that the combination of BCI and trametinib successfully cured the leukemia in mice. | Blood Adv. 2024 Jun 11;8(11):2765-2776. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.15mL 0.63mL 0.32mL |
15.75mL 3.15mL 1.58mL |
31.50mL 6.30mL 3.15mL |
|
| CAS号 | 1245792-51-1 |
| 分子式 | C22H23NO |
| 分子量 | 317.42 |
| SMILES Code | O=C1/C(C(NC2CCCCC2)C3=C1C=CC=C3)=C/C4=CC=CC=C4 |
| MDL No. | MFCD20232928 |
| 别名 | (E)-BCI |
| 运输 | 蓝冰 |
| InChI Key | XJDKPLZUXCIMIS-HMMYKYKNSA-N |
| Pubchem ID | 6419844 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 120 mg/mL(378.04 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1